SCHEMBL1703327

SCHEMBL1703327

Fc1cccc(C2(N3CCC3)CCC3(CC2)OCCO3)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.42
SLC6A9 P48067 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
GRIN1 Q05586 3/20 0.40
GRIN2A Q12879 3/20 0.40
GRIN2B Q13224 3/20 0.40
SLC6A4 P31645 3/20 0.40
SLC6A3 Q01959 3/20 0.40
PRCP P42785 2/20 0.40
SLC6A2 P23975 2/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
CYP2B6 P20813 1/20 0.40
KCNH2 Q12809 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2000579 0.99 OPRM1 (0.41) OPRM1SLC6A9HDAC3HDAC1HDAC2
SCHEMBL733824 0.82 SIGMAR1 (0.59) OPRM1SLC6A9GRIN1GRIN2AGRIN2B
SCHEMBL23595709 0.82 GRIN1 (0.59) OPRM1SLC6A9GRIN1GRIN2AGRIN2B
SCHEMBL2200621 0.79 SIGMAR1 (0.64) OPRM1SLC6A9GRIN1GRIN2AGRIN2B
SCHEMBL1703199 0.77 OPRM1 (0.48) OPRM1SLC6A9GRIN1GRIN2AGRIN2B
SCHEMBL731991 0.75 OPRL1 (0.49) OPRM1HDAC3HDAC1HDAC2HDAC6
SCHEMBL18132846 0.75 HDAC3 (0.46) HDAC3HDAC1HDAC2HDAC6SLC6A4
SCHEMBL13361652 0.74 PRCP (0.46) OPRM1SLC6A9GRIN1GRIN2AGRIN2B
SCHEMBL526471 0.72 OPRM1 (0.52) OPRM1HDAC3HDAC1HDAC2HDAC6
SCHEMBL3941642 0.72 SIGMAR1 (0.49) OPRM1SLC6A9GRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121691-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2012-04-18 EP disclosed
US-7960404-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2011-06-14 US disclosed
US-20100048553-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
EP-2121691-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2009-11-25 EP disclosed
WO-2008101660-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048553-A1 Spirocyclic Cyclohexane Compounds PKD2, PKD1, RYR1 OPRM1 65/4885SLC6A9 3386/4885HDAC3 2002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.